tirzepatide mcas A newly published case series reports that GLP-1 receptor agonists (like semaglutide and tirzepatide) may significantly improve symptoms in patients with mast cell activation syndrome (MCAS), even in those without diabetes or A newly published case series

Amy Schumers weight loss with Ozempic and Mounjaro highlights the real impact of GLP-1 meds

Weight Loss Treatment, Peptide Therapy, Anti-Aging Therapy, IV Drip Therapy, Sexual Health Treatment, Advanced Blood Testing, and General Wellness.

We analyze the of characteristics all the De Novo classification requests to date, including the submission type, trends, FDA review times, and device types

Experts share their concerns and the need for more information.

Key topics included the effectiveness of oral semaglutide in clinical practice, the positioning of the agent to optimize the treatment benefits, the possibility to adopt flexibility in the administration schedule, critical issues encountered, the role of patient communication and information in the importance of dose escalation and management of adverse events

Read the full...